Navigation Links
UC Berkeley Expands Molecular Toxicology Curriculum to Include GeneGo's Platform
Date:1/8/2008

ST. JOSEPH, Mich., Jan. 8 /PRNewswire/ -- GeneGo, Inc., the leading provider of databases, software and services in systems biology, announced today that UC Berkeley will expand the use of its MetaCore/MetaDrug Discovery Platform in their Computational Toxicology course, a required component for Molecular Toxicology majors, and in undergrad honors research programs. The agreement will provide students with chemical structure, network and pathway analysis tools needed to analyze complex omics datasets and to predict and understand the beneficial and potentially harmful effects of chemicals in humans and other species.

"When we designed our Computational Toxicology course a few years ago we anticipated a shift in the future toward 'systems biology' that is, looking at the complex interactions of metabolic, genetic, protein, and cellular elements with the goal of modeling entire systems in relation to chemical stresses," said Dale Johnson, Pharm.D., Ph.D., Adjunct Professor, who designed and teaches the Computational Toxicology course. "The complexity of these chemical/biological interactions resulting from environmental exposures, food sources, or pharmaceutical compounds, highlights our thinking that an overall systems approach will be necessary if relevant advances are to be made in applying computational solutions. GeneGo has presented us with an outstanding platform that continues to grow in functionality each year. We are extremely pleased to be able to utilize MetaCore/MetaDrug as the core part of our coursework."

"We are pleased with the decision of UC Berkeley's Department of Nutritional Sciences and Toxicology to include our tools in its curriculum, which is one of the very best in the world," said Julie Bryant, Vice President of Business Development for GeneGo. "The study of fundamental biology is changing quickly with omics technology and systems level analysis, and these changes affect application fields such as toxicology. UC Berkeley
'/>"/>

SOURCE GeneGo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Advanced Immune Support Formula Licensed From UC Berkeley Launched
2. Observant LLC Expands Senior Management Team
3. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
4. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
5. CSL Behring Expands Into Middle East Market with Haemate(R) P
6. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
7. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
8. Siemens Expands the SOMATOM Definition(TM) Line With Worlds First Adaptive CT Scanner
9. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
10. Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
11. Imaging Diagnostic Systems Expands Key Patent Coverage

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cyto...ldt, PhD to its Board of Directors. Dr. Moldt will...ative on the Company,s Board. The number of Board ...e are very pleased to welcome Peter Moldt to the b...ience and guidance as Cytochroma continues to make...
(Date:11/24/2009)... This release is available in German . , Wh...ion cards: RFID tags (Radio Frequency Identificati...ay life. They make it possible to label objects or...equency. The appropriate scanner can read and proc...can be affixed to goods under production condition...
(Date:11/24/2009)..., , SANTA CRUZ, Calif., Nov. 24 /PRNewsw...ned Bio Career Center, the nation,s leading online...ssionals. ,, Northwestern and Columbia Universi...her major life science training Institutions. ,...y for post-graduates in the life sciences. While t...
(Date:11/24/2009)... Health care employment g...ns the only one to show consistent growth during t...hospitals remain in trouble, and health systems ar...personnel, instead of just administrators. , ...ealth care employment continued growing in October...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...AMIR, Israel, Jan. 14 Shamir,Optical Industry Ltd...of,innovative products and technology to the progr...t its board of directors had declared a dividend,d...ion (approximately NIS,15.1 million based on the J...or approximately US$ 0.243 (approximately NIS 0.91...
...nd HAIKOU, China, Jan. 14 /Xinhua-PRNewswire-First...a,) (OTC Bulletin Board: CPHI),which develops, man...aceutical products in China, today announced that ...itiate a proactive and targeted investor,relations...I, and their,collective team, will be advising the...
...an. 14 Today, The Woodbridge Group announced,the ...industry,s highest,levels of "Green" Polyurethane ...e strategy, BioFoam, a patented technology, substi...ing of polyurethane products. This,earth-friendly ...,applications includes; seat cushions, seat fabric...
Other Biology Technology:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 2China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 3Woodbridge Offers the Broadest Range of BioFoam(TM) 'Green' Polyurethane Automotive Interior Applications 2
(Date:11/26/2009)...cus Aureus ) and other drug-resistant bacteria cou...totype devices have been developed to offer safe, ..., Two prototype devices have been developed: one...hands and feet) in hospitals and public spaces whe...to shoot bacteria-killing agents into infested chr...
(Date:11/25/2009)...ath Research Laboratory in the University of Haifa...stigious Johnson & Johnson Focused Funding grant f...damage in Parkinson,s disease. The award, which is...ovation and excellence in science, was announced i...h at an event at the Hyatt Regency Hotel in New Je...
(Date:11/24/2009)...ribed by traditional healers in Brazil to treat a ...to fever and flu. , Now for the first time, resea...cientifically prove the pain relieving properties ...mint. , Testing this ancient South American herb ... was able to show that when prepared as a ,tea, t...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Celebrate June Is Dairy Month Beginning With Breakfast 48128 1Celebrate June Is Dairy Month Beginning With Breakfast 48128 2Windows XP Vista and Windows 7 Compatible Remote Control 4 0 Beta Released by IntelliAdmin LLC 48124 1Windows XP Vista and Windows 7 Compatible Remote Control 4 0 Beta Released by IntelliAdmin LLC 48124 2Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 1Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 2Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 3Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 4Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 5Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 6Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 7Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 8
... variations ensure that no two people are exactly .... Now, researchers have the tools and the knowled... cancer therapies, enabling them to create more ef...ized medicine. At the 2007 Annual Meeting of the A...rs present new biomarkers ?and techniques for dete...
...by" hysteria of the 1980s was greatly exaggerated,... disabling cognitive impairments -- attention defi.... , A recent study by investigators at the Vander...ent may help explain the long-term behavioral and ...osure to cocaine. In a recent issue of the Journal...
...e that nanoparticles, engineered materials about a...d lead to cancer, according to research presented ...tion for Cancer Research. , Nanoparticles are smal... yet they are large enough to cause trouble by int...t the University of Massachusetts say. Such nanop...
Other Biology News:Genes and biomarkers that allow doctors to choose the right therapy for the right patient 2Genes and biomarkers that allow doctors to choose the right therapy for the right patient 3Genes and biomarkers that allow doctors to choose the right therapy for the right patient 4Genes and biomarkers that allow doctors to choose the right therapy for the right patient 5Genes and biomarkers that allow doctors to choose the right therapy for the right patient 6Prenatal cocaine's lasting cellular effects 2Prenatal cocaine's lasting cellular effects 3Cancer tip -- Nanoparticles can damage DNA, increase cancer risk 2
...apidCycler is the first instrument engineered to m...d by thousands of research centers worldwide. It u... are ideally suited for high-speed temperature cyc...rface-area-to-volume ratio. ,By combining glass c...
Freund's Incomplete Adjuvant, Modified from Calbiochem
...RY Array LNA microarray slides for microRNA expre...ides incorporate Exiqons unique Locked Nucleic Aci...ty and excellent mismatch discrimination for short... on less than 1 g total RNA (no need for microRNA ...
Tyrode's Salts solution from Sigma-Aldrich
Biology Products: